Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-12-12 Purchase |
2024-12-16 4:26 pm |
TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner |
131,800 | $2.9269 | $385,769 | 5,357,347 (Indirect) |
View |
| 2024-11-15 Purchase |
2024-11-19 4:26 pm |
TScan Therapeutics Inc. | TCRX | Lynx1 Capital Management LP Nichols Weston 10% Owner |
947 | $4.3442 | $4,114 | 5,225,547 (Indirect) |
View |
| 2024-09-23 Purchase |
2024-09-24 5:26 pm |
TScan Therapeutics Inc. | TCRX | Klencke Barbara Director |
5,000 | $5.29 | $26,450 | 70,000 (Indirect Direct) |
View |
| 2024-08-23 Purchase |
2024-08-27 6:57 pm |
TScan Therapeutics Inc. | TCRX | Klencke Barbara Director |
10,000 | $5.61 | $56,100 | 65,000 (Indirect Direct) |
View |
| 2024-08-23 Sale |
2024-08-27 6:46 pm |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
164,686 | $5.7814 | $952,116 | 447,530 (Direct) |
View |
| 2023-12-18 Purchase |
2023-12-21 5:00 pm |
TScan Therapeutics Inc. | TCRX | BARBERICH TIMOTHY J Director |
29,147 | $4.8875 | $142,456 | 100,286 (Indirect Direct) |
View |
| 2023-12-14 Purchase |
2023-12-18 6:01 pm |
TScan Therapeutics Inc. | TCRX | Klencke Barbara Director |
5,000 | $5.08 | $25,400 | 55,000 (Indirect Direct) |
View |
| 2023-06-02 Purchase |
2023-06-06 7:53 pm |
TScan Therapeutics Inc. | TCRX | BARBERICH TIMOTHY J Director |
37,880 | $2.6284 | $99,564 | 71,139 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-12 Option Award |
2025-02-11 5:54 pm |
N/A 2034-01-12 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
302,500 | $0 | 302,500 (Direct) |
View |
| 2024-01-12 Option Award |
2025-02-11 5:54 pm |
N/A 2034-01-12 |
TScan Therapeutics Inc. | TCRX | Dworak Leiden Vice President, Finance |
46,875 | $0 | 46,875 (Direct) |
View |
| 2024-01-12 Option Award |
2025-02-11 5:52 pm |
N/A 2034-01-12 |
TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Executive Officer |
960,000 | $0 | 960,000 (Direct) |
View |
| 2025-01-03 Option Award |
2025-02-11 5:47 pm |
N/A 2035-01-03 |
TScan Therapeutics Inc. | TCRX | Amello Jason Chief Financial Officer |
270,000 | $0 | 270,000 (Direct) |
View |
| 2025-01-03 Option Award |
2025-02-11 5:47 pm |
N/A 2035-01-03 |
TScan Therapeutics Inc. | TCRX | Louis Chrystal Chief Medical Officer |
400,000 | $0 | 400,000 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
64,166 | $2.49 | 447,530 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
13,125 | $1.81 | 447,530 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
54,895 | $4.85 | 447,530 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
25,000 | $3.27 | 447,530 (Direct) |
View |
| 2024-08-23 Exercise |
2024-08-27 6:46 pm |
N/A 2032-01-17 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN See Remarks |
157,186 | $0 | 447,530 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:20 pm |
N/A 2034-06-11 |
TScan Therapeutics Inc. | TCRX | Woods Keith Director |
47,500 | $0 | 47,500 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:20 pm |
N/A 2034-06-11 |
TScan Therapeutics Inc. | TCRX | Dorton Katina Director |
47,500 | $0 | 47,500 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:20 pm |
N/A 2034-06-11 |
TScan Therapeutics Inc. | TCRX | Klencke Barbara Director |
47,500 | $0 | 47,500 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:20 pm |
N/A 2034-06-11 |
TScan Therapeutics Inc. | TCRX | Gruia Gabriela Director |
47,500 | $0 | 47,500 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:20 pm |
N/A 2034-06-11 |
TScan Therapeutics Inc. | TCRX | Nicholson Garry A Director |
71,250 | $0 | 71,250 (Direct) |
View |
| 2024-06-12 Option Award |
2024-06-14 4:13 pm |
N/A 2034-06-11 |
TScan Therapeutics Inc. | TCRX | BAKER BROS. ADVISORS LP 667 L.P. Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director |
95,000 | $0 | 95,000 (Indirect) |
View |
| 2024-05-01 Option Award |
2024-05-03 4:05 pm |
N/A 2034-04-30 |
TScan Therapeutics Inc. | TCRX | Louis Chrystal Chief Medical Officer |
380,000 | $0 | 380,000 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 4:21 pm |
N/A 2034-01-31 |
TScan Therapeutics Inc. | TCRX | Amello Jason Chief Financial Officer |
750,000 | $0 | 750,000 (Direct) |
View |
| 2023-12-06 Option Award |
2023-12-08 08:20 am |
N/A 2033-12-05 |
TScan Therapeutics Inc. | TCRX | Woods Keith Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2023-07-21 Option Award |
2023-07-24 7:39 pm |
N/A 2033-07-20 |
TScan Therapeutics Inc. | TCRX | Dworak Leiden Chief Accounting Officer |
25,000 | $0 | 25,000 (Direct) |
View |
Ownership |
2023-07-24 7:31 pm |
N/A N/A |
TScan Therapeutics Inc. | TCRX | Dworak Leiden Chief Accounting Officer |
0 | $0 | 235,742 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:25 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | BARBERICH TIMOTHY J Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:19 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | Barton Debora Chief Medical Officer |
430,000 | $0 | 430,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:17 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | Dorton Katina Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:14 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | Gruia Gabriela Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:13 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | Klencke Barbara Director |
36,524 | $0 | 36,524 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:09 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | Silver Brian M. Chief Financial Officer |
632,500 | $0 | 632,500 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:08 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | MacBeath Gavin Chief Executive Officer |
1,121,300 | $0 | 1,121,300 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 6:01 pm |
N/A 2033-06-12 |
TScan Therapeutics Inc. | TCRX | ZDRAVESKI ZORAN Chief Legal Officer |
430,000 | $0 | 430,000 (Direct) |
View |
| 2023-06-13 Option Award |
2023-06-15 4:40 pm |
N/A 2033-06-13 |
TScan Therapeutics Inc. | TCRX | BAKER BROS. ADVISORS LP 667 L.P. BAKER FELIX BAKER JULIAN Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
70,000 | $0 | 70,000 (Indirect) |
View |